• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一对近端正电荷为 LRP(低密度脂蛋白受体相关蛋白)的补体样结构域提供了主要的配体结合贡献。

A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low-density lipoprotein receptor-related protein).

机构信息

Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.

出版信息

Biochem J. 2012 Apr 1;443(1):65-73. doi: 10.1042/BJ20111867.

DOI:10.1042/BJ20111867
PMID:22181833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3304490/
Abstract

The LRP (low-density lipoprotein receptor-related protein) can bind a wide range of structurally diverse ligands to regions composed of clusters of ~40 residue Ca2+-dependent, disulfide-rich, CRs (complement-like repeats). Whereas lysine residues from the ligands have been implicated in binding, there has been no quantification of the energetic contributions of such interactions and hence of their relative importance in overall affinity, or of the ability of arginine or histidine residues to bind. We have used four representative CR domains from the principal ligand-binding cluster of LRP to determine the energetics of interaction with well-defined small ligands that include methyl esters of lysine, arginine, histidine and aspartate, as well as N-terminally blocked lysine methyl ester. We found that not only lysine but also arginine and histidine bound well, and when present with an additional proximal positive charge, accounted for about half of the total binding energy of a protein ligand such as PAI-1 (plasminogen activator inhibitor-1). Two such sets of interactions, one to each of two CR domains could thus account for almost all of the necessary binding energy of a real ligand such as PAI-1. For the CR domains, a central aspartate residue in the sequence DxDxD tightens the Kd by ~20-fold, whereas DxDDD is no more effective. Together these findings establish the rules for determining the binding specificity of protein ligands to LRP and to other LDLR (low-density lipoprotein receptor) family members.

摘要

LRP(低密度脂蛋白受体相关蛋白)可以结合广泛的结构多样的配体到由约 40 个残基组成的簇区域,这些区域含有 Ca2+依赖性、富含二硫键的 CR(补体样重复)。虽然配体中的赖氨酸残基与结合有关,但尚未对这些相互作用的能量贡献进行定量,因此也无法确定它们在整体亲和力中的相对重要性,或者精氨酸或组氨酸残基结合的能力。我们使用 LRP 的主要配体结合簇中的四个代表性 CR 结构域来确定与明确定义的小分子配体相互作用的能量,这些配体包括赖氨酸、精氨酸、组氨酸和天冬氨酸的甲酯,以及 N-末端封闭的赖氨酸甲酯。我们发现,不仅赖氨酸,而且精氨酸和组氨酸也能很好地结合,并且当与另外一个近端正电荷结合时,它们占蛋白质配体(如 PAI-1(纤溶酶原激活物抑制剂-1))总结合能的约一半。这样的两个相互作用组,每个 CR 结构域一个,可以解释几乎所有真实配体(如 PAI-1)所必需的结合能。对于 CR 结构域,序列中的中央天冬氨酸残基使 Kd 约增加 20 倍,而 DxDDD 则没有更有效。这些发现共同确立了确定蛋白质配体与 LRP 和其他 LDLR(低密度脂蛋白受体)家族成员结合特异性的规则。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/cfb4c8ba929a/bic888i005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/fc8b3cde9d67/bic888i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/4e7692826d94/bic888i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/78bf0cad665c/bic888i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/b49bc3e8ece8/bic888i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/cfb4c8ba929a/bic888i005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/fc8b3cde9d67/bic888i001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/4e7692826d94/bic888i002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/78bf0cad665c/bic888i003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/b49bc3e8ece8/bic888i004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc81/3304490/cfb4c8ba929a/bic888i005.jpg

相似文献

1
A proximal pair of positive charges provides the dominant ligand-binding contribution to complement-like domains from the LRP (low-density lipoprotein receptor-related protein).一对近端正电荷为 LRP(低密度脂蛋白受体相关蛋白)的补体样结构域提供了主要的配体结合贡献。
Biochem J. 2012 Apr 1;443(1):65-73. doi: 10.1042/BJ20111867.
2
Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.低密度脂蛋白受体相关蛋白中尿激酶型纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物双结构域结合位点的分析
Biochem J. 2001 Jul 1;357(Pt 1):289-96. doi: 10.1042/0264-6021:3570289.
3
Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.低密度脂蛋白受体相关蛋白补体样重复序列第二簇与配体结合的分子分析。受体相关蛋白介导的配体结合抑制中变构成分的证据。
J Biol Chem. 1997 May 23;272(21):13608-13. doi: 10.1074/jbc.272.21.13608.
4
A single lysine of the two-lysine recognition motif of the D3 domain of receptor-associated protein is sufficient to mediate endocytosis by low-density lipoprotein receptor-related protein.D3 结构域受体相关蛋白的双赖氨酸识别基序中的一个赖氨酸足以介导低密度脂蛋白受体相关蛋白的内吞作用。
Int J Biochem Cell Biol. 2011 Mar;43(3):431-40. doi: 10.1016/j.biocel.2010.11.017. Epub 2010 Dec 7.
5
Three complement-like repeats compose the complete alpha2-macroglobulin binding site in the second ligand binding cluster of the low density lipoprotein receptor-related protein.三个补体样重复序列构成低密度脂蛋白受体相关蛋白第二个配体结合簇中的完整α2-巨球蛋白结合位点。
J Biol Chem. 2006 Nov 10;281(45):34189-96. doi: 10.1074/jbc.M604389200. Epub 2006 Sep 18.
6
Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.低密度脂蛋白受体相关蛋白与E族丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1和蛋白酶连接蛋白-1不同构象状态的结合特异性。
J Biol Chem. 2009 Jul 3;284(27):17989-97. doi: 10.1074/jbc.M109.009530. Epub 2009 May 13.
7
Dissection of RAP-LRP interactions: binding of RAP and RAP fragments to complement-like repeats 7 and 8 from ligand binding cluster II of LRP.RAP-LRP相互作用的剖析:RAP及RAP片段与LRP配体结合簇II中补体样重复序列7和8的结合
Arch Biochem Biophys. 2006 Jun 15;450(2):167-75. doi: 10.1016/j.abb.2006.04.007. Epub 2006 May 5.
8
Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII.参与与凝血因子VIII的A2结构域结合的低密度脂蛋白受体相关蛋白区域的定位。
Thromb Haemost. 2007 Dec;98(6):1170-81.
9
Quantitative dissection of the binding contributions of ligand lysines of the receptor-associated protein (RAP) to the low density lipoprotein receptor-related protein (LRP1).定量剖析受体相关蛋白 (RAP) 配体赖氨酸与低密度脂蛋白受体相关蛋白 (LRP1) 结合的贡献。
J Biol Chem. 2013 Aug 16;288(33):24081-90. doi: 10.1074/jbc.M113.473728. Epub 2013 Jun 23.
10
Ca2+ binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein.钙离子与低密度脂蛋白受体相关蛋白的补体样重复结构域5和6结合。
BMC Biochem. 2003 Aug 18;4:7. doi: 10.1186/1471-2091-4-7.

引用本文的文献

1
Prognostic significance of alpha-2-macrglobulin and low-density lipoprotein receptor-related protein-1 in various cancers.α-2-巨球蛋白和低密度脂蛋白受体相关蛋白-1在各种癌症中的预后意义
Am J Cancer Res. 2024 Jun 15;14(6):3036-3058. doi: 10.62347/VUJV9180. eCollection 2024.
2
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor.凝血因子 VIII 与患者来源的抗 C1 结构域抗体抑制剂复合物的结构。
Blood. 2023 Jul 13;142(2):197-201. doi: 10.1182/blood.2023020181.
3
The Antimicrobial Peptide AMP-IBP5 Suppresses Dermatitis-like Lesions in a Mouse Model of Atopic Dermatitis through the Low-Density Lipoprotein Receptor-Related Protein-1 Receptor.

本文引用的文献

1
A single lysine of the two-lysine recognition motif of the D3 domain of receptor-associated protein is sufficient to mediate endocytosis by low-density lipoprotein receptor-related protein.D3 结构域受体相关蛋白的双赖氨酸识别基序中的一个赖氨酸足以介导低密度脂蛋白受体相关蛋白的内吞作用。
Int J Biochem Cell Biol. 2011 Mar;43(3):431-40. doi: 10.1016/j.biocel.2010.11.017. Epub 2010 Dec 7.
2
Structure of the minimal interface between ApoE and LRP.载脂蛋白 E 和 LRP 之间最小界面的结构。
J Mol Biol. 2010 Apr 30;398(2):306-19. doi: 10.1016/j.jmb.2010.03.022. Epub 2010 Mar 19.
3
Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.
抗菌肽 AMP-IBP5 通过低密度脂蛋白受体相关蛋白-1 受体抑制特应性皮炎小鼠模型中的皮炎样损伤。
Int J Mol Sci. 2023 Mar 8;24(6):5200. doi: 10.3390/ijms24065200.
4
High-affinity binding of plasminogen-activator inhibitor 1 complexes to LDL receptor-related protein 1 requires lysines 80, 88, and 207.高亲和力结合物纤溶酶原激活物抑制剂 1 复合物到 LDL 受体相关蛋白 1 需要赖氨酸 80、88 和 207。
J Biol Chem. 2020 Jan 3;295(1):212-222. doi: 10.1074/jbc.RA119.010449. Epub 2019 Dec 2.
5
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.与癌症选择性硫酸乙酰肝素靶向分支肽偶联可绕过乳腺癌细胞对甲氨蝶呤的耐药性。
Oncotarget. 2017 Jul 6;8(44):76141-76152. doi: 10.18632/oncotarget.19056. eCollection 2017 Sep 29.
6
Interaction of Fibrin with the Very Low-Density Lipoprotein (VLDL) Receptor: Further Characterization and Localization of the VLDL Receptor-Binding Site in Fibrin βN-Domains.纤维蛋白与极低密度脂蛋白(VLDL)受体的相互作用:纤维蛋白βN结构域中VLDL受体结合位点的进一步表征与定位
Biochemistry. 2017 May 16;56(19):2518-2528. doi: 10.1021/acs.biochem.7b00087. Epub 2017 May 2.
7
Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.抑制性丝氨酸蛋白酶抑制剂。对其折叠、聚合、调节和清除的新见解。
Biochem J. 2016 Aug 1;473(15):2273-93. doi: 10.1042/BCJ20160014.
8
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe.通过使用分支肽探针深入了解硫酸化聚糖在癌细胞黏附和迁移中的作用。
Sci Rep. 2016 Jun 3;6:27174. doi: 10.1038/srep27174.
9
The High Affinity Binding Site on Plasminogen Activator Inhibitor-1 (PAI-1) for the Low Density Lipoprotein Receptor-related Protein (LRP1) Is Composed of Four Basic Residues.纤溶酶原激活物抑制剂-1(PAI-1)上与低密度脂蛋白受体相关蛋白(LRP1)结合的高亲和力位点由四个碱性残基组成。
J Biol Chem. 2016 Jan 8;291(2):800-12. doi: 10.1074/jbc.M115.688820. Epub 2015 Nov 10.
10
Factor VIII Interacts with the Endocytic Receptor Low-density Lipoprotein Receptor-related Protein 1 via an Extended Surface Comprising "Hot-Spot" Lysine Residues.凝血因子VIII通过包含“热点”赖氨酸残基的扩展表面与内吞受体低密度脂蛋白受体相关蛋白1相互作用。
J Biol Chem. 2015 Jul 3;290(27):16463-76. doi: 10.1074/jbc.M115.650911. Epub 2015 Apr 21.
低密度脂蛋白受体相关蛋白与E族丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1和蛋白酶连接蛋白-1不同构象状态的结合特异性。
J Biol Chem. 2009 Jul 3;284(27):17989-97. doi: 10.1074/jbc.M109.009530. Epub 2009 May 13.
4
Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): consequences for the chaperone functions of RAP.受体相关蛋白(RAP)对低密度脂蛋白受体相关蛋白(LRP)有两个高亲和力结合位点:对RAP分子伴侣功能的影响
Biochem J. 2009 Jun 26;421(2):273-82. doi: 10.1042/BJ20090175.
5
Unfolding of the RAP-D3 helical bundle facilitates dissociation of RAP-receptor complexes.RAP-D3螺旋束的展开促进了RAP-受体复合物的解离。
Biochemistry. 2008 Feb 12;47(6):1532-9. doi: 10.1021/bi702076y. Epub 2008 Jan 5.
6
Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.通过定点诱变确定尿激酶型纤溶酶原激活剂-纤溶酶原激活剂抑制剂-1复合物与低密度脂蛋白受体家族内吞作用受体的结合区域。
FEBS J. 2006 Nov;273(22):5143-59. doi: 10.1111/j.1742-4658.2006.05511.x. Epub 2006 Oct 17.
7
Three complement-like repeats compose the complete alpha2-macroglobulin binding site in the second ligand binding cluster of the low density lipoprotein receptor-related protein.三个补体样重复序列构成低密度脂蛋白受体相关蛋白第二个配体结合簇中的完整α2-巨球蛋白结合位点。
J Biol Chem. 2006 Nov 10;281(45):34189-96. doi: 10.1074/jbc.M604389200. Epub 2006 Sep 18.
8
RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi.RAP利用组氨酸开关来调节其在内质网和高尔基体中与LRP的相互作用。
Mol Cell. 2006 May 5;22(3):423-30. doi: 10.1016/j.molcel.2006.04.011.
9
Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors.低密度脂蛋白受体-受体相关蛋白复合物的结构揭示了脂蛋白受体识别配体的一般模式。
Mol Cell. 2006 Apr 21;22(2):277-83. doi: 10.1016/j.molcel.2006.02.021.
10
Mutation of lysine 1370 in full-length human alpha2-macroglobulin blocks binding to the low density lipoprotein receptor-related protein-1.全长人α2-巨球蛋白中赖氨酸1370的突变会阻断其与低密度脂蛋白受体相关蛋白1的结合。
Arch Biochem Biophys. 2005 Jun 1;438(1):29-35. doi: 10.1016/j.abb.2005.03.019. Epub 2005 Apr 9.